Therapeutic tissue regeneration by a macrophage colony-stimulating factor Fc conjugate.

1792–1802. 11. 11. Mortimer, SA, Kidwell, MA and Doudna, JA (2014). Insights into RNA structure and function from genome-wide studies. Nat Rev Genet 15: 469-479. 12. Hackett, PB Jr, Aronovich, EL, Hunter, D, Urness, M, Bell, JB, Kass, SJ et al. (2011). Efficacy and safety of Sleeping Beauty transposon-mediated gene transfer in preclinical animal studies. Curr Gene Ther 11: 341–349. 13. Howe, SJ, Mansour, MR, Schwarzwaelder, K, Bartholomae, C, Hubank, M, Kempski, H et al. (2008). Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J Clin Invest 118: 3143–3150. 14. Vogler, C, Levy, B, Grubb, JH, Galvin, N, Tan, Y, Kakkis, E et al. (2005). Overcoming the blood–brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII. Proc Natl Acad Sci USA 102: 14777–14782. 15. Aronovich, EL, Bell, JB, Khan, SA, Belur, LR, Gunther, R, Koniar, B et al. (2009). Systemic correction of storage disease in MPS I NOD/SCID mice using the Sleeping Beauty transposon system. Mol Ther 17, 1136–1144. 16. Nayak, S and Herzog, RW (2010). Progress and prospects: immune responses to viral vectors. Gene Ther 17: 295–304. 5. Liu, F, Song, Y and Liu, D (1999). Hydrodynamicsbased transfection in animals by systemic administration of plasmid DNA. Gene Ther 6: 1258–1266. 6. Zhang, G, Budker, V and Wolff, J (1999). A. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum Gene Ther 10: 1735–1737. 7. Nair, N, Rincon, MY, Evens, H, Sarcar, S, Dastidar, S, Samara-Kuko, E et al. (2014). Computationally designed liver-specific transcriptional modules and hyperactive factor IX improve hepatic gene therapy. Blood 123: 3195–3199. 8. Dunn, TM, Hahn, S, Ogden, S and Schleif, RF (1984). An operator at –280 base pairs that is required for repression of araBAD operon promoter: addition of DNA helical turns between the operator and promoter cyclically hinders repression. Proc Natl Acad Sci USA 81, 5017–5020. 9. Aronovich, EL, Hall, BC, Bell, JB, McIvor, RS and Hackett, PB (2013). Quantitative analysis of a-liduronidase expression in immunocompetent mice treated with the Sleeping Beauty transposon system. PLoS One 8: e78161. 10 Bell, JB, Aronovich, EL, Schreifels, JM, Beadnell, TC and Hackett, PB (2010). Duration of expression of Sleeping Beauty transposase in mouse liver following hydrodynamic DNA delivery. Mol Ther 18: